SJSuyoung Jo

Suyoung Jo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Suyoung Jo has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Influenza Vaccine Effectiveness in Korean Children: A Registry-Linked, Survey-Based Population Study (2023–2024)

    by Suyoung Jo, Min Young Kim, Seunghyun Lee, Huiseon Kim, Hyunji Won, Ji Young Lee, Jee Yeon Baek, Jong Gyun Ahn, Hye-Sook Jeong, June-Woo Lee, et al.

    Jo S, et al. J Korean Med Sci. 2027 Jan;42:e8. https://doi.org/10.3346/jkms.2027.42.e8

  • Open Access

    Employment type and non-compliance with SARS-CoV-2 diagnostic testing: insights from a nationwide seroprevalence study in South Korea

    by Youngook Jang, Kyuhyun Yoon, Suyoung Jo, Jina Han, Jung Ae Kim, Hye Jin Baek, Jaehun Jung, Hyejin Joo, Yumi Jang, June-Woo Lee, et al.

    Objectives: To assess variations in compliance with SARS-CoV-2 diagnostic testing by examining the prevalence of unreported infections according to socioeconomic factors including occupation and employment type. We hypothesised that individuals in more precarious employment conditions would be less likely to undergo COVID-19 testing. Design: Nationwide follow-up survey linked to a prior seroprevalence study (K-SEROSMART). Setting: General population-based study conducted across 258 counties in South Korea. Participants: The final analysis included 4502 individuals aged 19 years and older who completed both the socioeconomic survey and SARS-CoV-2 antibody testing and were reactive for anti-nucleocapsid (N) antibodies. Primary outcome measures: The primary outcome was non-compliance with COVID-19 diagnostic testing, defined as the absence of a self-reported confirmed diagnosis among individuals who tested reactive for anti-SARS-CoV-2 nucleocapsid (N) antibodies, indicating a history of natural infection. Results: Non-compliance with diagnostic testing was significantly associated with socioeconomic characteristics. Self-employed individuals (adjusted OR (aOR) 1.97, 95% CI 1.47 to 2.65) and non-regular workers (aOR 1.45, 95% CI 1.09 to 1.93) had higher odds of unreported infection compared with regular workers. In the analysis by occupational group, certain occupations showed significant associations in the univariate analysis; however, these associations did not retain statistical significance in the multivariable analysis. Conclusions: Socioeconomic disparities play an important role in compliance with COVID-19 diagnostic testing. Individuals in precarious employment may face barriers to testing, contributing to undetected infections. Policies that improve access to testing and reduce employment-related constraints, such as paid sick leave, may help mitigate these disparities. Future research should investigate the specific reasons underlying non-compliance with testing and assess its contribution to community transmission.

  • Open Access

    Protective Effectiveness of Sars-Cov-2 Infection Risk Among Hybrid, Vaccine, and Infection-induced Immunity Against the Omicron Variant, K-Serosmart

    by Yifan Zhang, Won Chang, Kevin Dieckhaus, Suyoung Jo, Jina Han, Hye Jin Baek, Eunbi Noh, Kyuhyun Yoon, Jung Ae Kim, Jaehun Jung, et al.

    Background: Estimating infection risk from SARS-CoV-2 Omicron and post-Omicron sub-variants is challenging due to the high number of unconfirmed infections. We compared breakthrough infection risks among individuals with hybrid, vaccine-only, and infection-only immunity in South Korea, incorporating laboratory-confirmed and serology-inferred infections. Methods: Using nationwide surveillance data (August–December 2022), immunity was classified by vaccination history and spike (S) and nucleocapsid (N) antibody profiles. Outcomes were assessed using two definitions: conservative (laboratory-confirmed cases) and inclusive (serology-inferred infections identified by changes in N-antibody titers). Infection dates for unconfirmed events were imputed via predictive mean matching, enabling Kaplan–Meier analyses. Time-varying Cox models estimated log hazard ratios (log-HRs). Results: Including serology markedly increased four-month cumulative infection risk estimates: hybrid immunity rose from 2% to 20%, infection-only from 4% to 24%, and vaccine-only from 30% to 40%. With these additional infections, the relative advantage of hybrid immunity narrowed. Under the conservative definition, log-HRs declined for vaccine-only vs hybrid (4.10–2.34) and infection-only vs hybrid (1.56–0.31). Under the inclusive definition, the vaccine-only log-HR fell from 3.44 to 0.13, and the infection-only log-HR shifted from 3.31 to −0.56, indicating greater protection for infection-only immunity by month four. Conclusions: Because confirmed cases largely capture symptomatic disease, vaccination appears to provide added protection against severe outcomes, though this benefit wanes within months. The rapid decline of hybrid immunity and the large burden of unconfirmed infections highlight the need for routine serological surveillance to detect silent transmission and timely booster campaigns to mitigate severe disease during Omicron-driven waves.

  • Open Access

    Modeling epidemic and economic trade-offs under alternative COVID-19 isolation exit scenarios in South Korea

    by Suyoung Jo, Sung-Il Cho, Asaph Young Chun, Kyung-Duk Min

  • Open Access

    Cohort profile: the Korean National Health Examination Baseline (KNHEB) cohort for longitudinal health monitoring in South Korea

    by Suyoung Jo, Eunsil Cheon, Heewon Kang, Min Kyung Lim, Wankyo Chung, Sun Ha Jee, Keum Ji Jung, Yeun Soo Yang, Seong Yong Park, Sunmi Lee, et al.

    Background: The Korean National Health Examination Baseline (KNHEB) cohort was established in 2019 by the Korea Disease Control and Prevention Agency and the National Health Insurance Service to address research gaps and improve standardized monitoring of the health effects of smoking and other modifiable risk factors. It provides scientific evidence to inform national policies on tobacco control and other health determinants, aiming to reduce preventable mortality and disease burden in South Korea. Methods: The cohort includes 8,916,544 individuals aged ≥ 20 who underwent general health screenings in 2002–2003. It integrates three linked databases: insurance eligibility, medical visits (diagnostic codes, healthcare utilization), and health check-ups (behavioral risk factors, blood test results, etc.). Medical visit and health check-up data were collected until December 2018, while mortality records have been updated through 2019 and continue to be updated annually. At baseline, the mean age of participants was 44.2 years (SD 13.8). The mean follow-up duration was 16.2 years (SD 2.6) for health check-ups among all participants and 9.7 years (SD 4.6) for mortality among deceased individuals. The cohort enables long-term analysis of health outcomes, including cause-specific mortality based on death records and disease incidence identified through diagnostic codes and medical visit data. Findings to date: Analyses using the KNHEB cohort have provided key insights into smoking-related health risks. One study estimated that 60,213 smoking-attributable deaths occurred in South Korea in 2020, while another identified smoking intensity as the strongest predictor of all-cause mortality. Ongoing research include examining the effect of combined health-related factors (HRFs) on cause-specific mortality across age groups and investigating long-term smoking trajectories and alcohol consumption patterns in relation to major non-communicable diseases (NCDs). Conclusions: The KNHEB cohort provides a large-scale, population-based dataset that supports comprehensive analyses of the long-term effects of modifiable risk factors on NCDs. Its findings contribute to evidence-based policymaking in South Korea and offer comparative insights for global research on chronic disease prevention and risk factor management. Furthermore, its standardized data collection and integration with health records facilitate cross-country comparisons, reinforcing its value as a model for large-scale epidemiological studies on NCDs.


  • Open Access

    Risk of all-cause mortality by various cigarette smoking indices: A longitudinal study using the Korea National Health Examination Baseline Cohort in South Korea

    by Heewon Kang, Eunsil Cheon, Jieun Hwang, Suyoung Jo, Kyoungin Na, Seong Yong Park, Sung-Il Cho

    Introduction: Smoking behaviors can be quantified using various indices. Previous studies have shown that these indices measure and predict health risks differently. Additionally, the choice of measure differs depending on the health outcome of interest. We compared how each smoking index...


  • Open Access

    Smoking-attributable Mortality in Korea, 2020: A Meta-analysis of 4 Databases

    by Eunsil Cheon, Yeun Soo Yang, Suyoung Jo, Jieun Hwang, Keum Ji Jung, Sunmi Lee, Seong Yong Park, Kyoungin Na, Soyeon Kim, Sun Ha Jee, et al.

    Objectives: Estimating the number of deaths caused by smoking is crucial for developing and evaluating tobacco control and smoking cessation policies. This study aimed to determine smoking-attributable mortality (SAM) in Korea in 2020.Methods: Four large-scale cohorts from Korea were analyzed. A Cox proportional-hazards model was used to determine the hazard ratios (HRs) of smoking-related death. By conducting a meta-analysis of these HRs, the pooled HRs of smoking-related death for 41 diseases were estimated. Population-attributable fractions (PAFs) were calculated based on the smoking prevalence for 1995 in conjunction with the pooled HRs. Subsequently, SAM was derived using the PAF and the number of deaths recorded for each disease in 2020.Results: The pooled HR for all-cause mortality attributable to smoking was 1.73 for current men smokers (95% confidence interval [CI], 1.53 to 1.95) and 1.63 for current women smokers (95% CI, 1.37 to 1.94). Smoking accounted for 33.2% of all-cause deaths in men and 4.6% in women. Additionally, it was a factor in 71.8% of men lung cancer deaths and 11.9% of women lung cancer deaths. In 2020, smoking was responsible for 53 930 men deaths and 6283 women deaths, totaling 60 213 deaths.Conclusions: Cigarette smoking was responsible for a significant number of deaths in Korea in 2020. Monitoring the impact and societal burden of smoking is essential for effective tobacco control and harm prevention policies.


  • Open Access

    Dose-response risks of all-cause, cancer, and cardiovascular disease mortality according to sex-specific cigarette smoking pack-year quantiles

    by Jieun Hwang, Suyoung Jo, Heewon Kang, Eunsil Cheon, Sung-Il Cho

    Introduction: This study investigated the risks for all-cause death and death from cancer or cardiovascular diseases due to smoking status and behavior, focusing on differences in smoking duration and amount stratified by sex. Methods: The integrated Korean Genome and Epidemiology Study...


  • Open Access

    Symptoms and Conditions in Children and Adults up to 90 Days after SARS-CoV-2 Infection: A Retrospective Observational Study Utilizing the Common Data Model

    by Minjung Han, Taehee Chang, Hae-Ryoung Chun, Suyoung Jo, Yeongchang Jo, Dong Han Yu, Sooyoung Yoo, Sung-Il Cho

    Background/Objectives: There have been widespread reports of persistent symptoms in both children and adults after SARS-CoV-2 infection, giving rise to debates on whether it should be regarded as a separate clinical entity from other postviral syndromes. This study aimed to characterize the clinical presentation of post-acute symptoms and conditions in the Korean pediatric and adult populations. Methods: A retrospective analysis was performed using a national, population-based database, which was encoded using the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). We compared individuals diagnosed with SARS-CoV-2 to those diagnosed with influenza, focusing on the risk of developing prespecified symptoms and conditions commonly associated with the post-acute sequelae of COVID-19. Results: Propensity score matching yielded 1,656 adult and 343 pediatric SARS-CoV-2 and influenza pairs. Ninety days after diagnosis, no symptoms were found to have elevated risk in either adults or children when compared with influenza controls. Conversely, at 1 day after diagnosis, adults with SARS-CoV-2 exhibited a significantly higher risk of developing abnormal liver function tests, cardiorespiratory symptoms, constipation, cough, thrombophlebitis/thromboembolism, and pneumonia. In contrast, children diagnosed with SARS-CoV-2 did not show an increased risk for any symptoms during either acute or post-acute phases. Conclusions: In the acute phase after infection, SARS-CoV-2 is associated with an elevated risk of certain symptoms in adults. The risk of developing post-acute COVID-19 sequelae is not significantly different from that of having postviral symptoms in children in both the acute and post-acute phases, and in adults in the post-acute phase. These observations warrant further validation through studies, including the severity of initial illness, vaccination status, and variant types.